Yatharth Hospitals is set for a major expansion after US private equity firm Advent International agreed to invest ₹3,150 crore for a 24.9% stake in the hospital chain.
The investment will be made through a primary capital infusion, which means the money will go directly into Yatharth Hospitals. The company plans to use the funds to expand its hospital network, add beds and strengthen its medical infrastructure.
The deal was announced on September 17 and comes as India’s healthcare sector continues to attract large investments from global private equity firms. The transaction is subject to customary closing conditions.
The announcement also triggered a sharp movement in Yatharth Hospital shares. The stock gained nearly 9% on September 17 before extending its rally the following day. Shares climbed more than 10% during intraday trading on September 18, touching a fresh record high of around ₹1,183 on the NSE.
The stock had gained about 20% across the two trading sessions, reflecting strong investor interest in the deal and Yatharth’s expansion plans.
Yatharth Hospitals was founded in 2008 by the Tyagi family and has grown from a regional hospital operator into a sizeable multi-speciality healthcare network.
The company currently operates nine hospitals with around 2,800 operational beds. Its hospitals are spread across parts of North India, including Noida, Greater Noida, Faridabad and Jhansi-Orchha in Madhya Pradesh.
The hospital group has been steadily increasing its footprint through new facilities as well as acquisitions. Its next target is significantly larger.
Yatharth plans to increase its capacity to more than 5,000 beds over the next three years. The expansion is expected to include both new hospitals and the enlargement of existing facilities.
The ₹3,150-crore investment from Advent will give the company considerable financial headroom to pursue those plans.
The Tyagi family will continue to remain the largest shareholder following the transaction. Promoters currently hold more than half of the company’s shares, allowing the founding family to retain control while bringing Advent in as a strategic financial investor.
The partnership also gives Yatharth access to Advent’s experience in healthcare investments and in scaling businesses.
Advent has invested extensively in the healthcare sector globally and has backed several Indian healthcare businesses. Its investments in India include Apollo 24/7, CARE Hospitals, Bharat Serums and Vaccines, Cohance and Felix Pharma.
Advent said India’s healthcare market has significant room for growth as access to medical services improves and demand for quality healthcare increases.
Yatharth’s recent financial performance has added to the interest around the company. Its consolidated revenue for the quarter ended June 2026 rose 51% year-on-year to ₹392.7 crore.
The company also recorded a 7% increase in average revenue per occupied bed to ₹34,758 during the quarter.
Growing patient demand and higher utilisation have supported the expansion of organised hospital chains across India. At the same time, hospitals require substantial capital to build facilities, purchase medical equipment and develop specialised treatment centres.
This has made the sector an increasingly attractive destination for private equity investment in India.
Large global investors have been putting money into hospital chains and healthcare companies as consolidation gathers pace. The Yatharth-Advent transaction is the latest example of this trend.
The deal also comes at a time when healthcare companies are looking beyond individual hospitals and building larger regional networks. Scale can help hospitals spread costs, attract specialists and offer a wider range of treatments across multiple locations.
Yatharth’s expansion strategy follows this model. The company is looking to increase its presence while adding more specialised services and increasing bed capacity.
The immediate response from the stock market has been positive, with Yatharth Hospital stock reaching a new high after the announcement. The larger test will be how effectively the company converts the new investment into additional capacity and sustainable growth.
With the founding family retaining control and Advent taking a substantial minority stake, the deal sets the stage for Yatharth’s next phase of expansion.
The ₹3,150-crore investment could help the hospital group move beyond its current regional footprint and build a significantly larger presence in India’s competitive healthcare market.